4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0001136261-14-000074
CIK 0000890465operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 11:29 AM ET
Size
8.9 KB
Accession
0001136261-14-000074
Insider Transaction Report
Form 4
Melrose Glenn R
SVP, Human Resources
Transactions
- Tax Payment
Common Stock
2014-02-13$38.30/sh−2,165$82,920→ 26,971 total - Exercise/Conversion
Common Stock
2014-02-13+6,075→ 29,136 total - Exercise/Conversion
Restricted Stock Units
2014-02-13−6,075→ 12,151 totalExercise: $0.00→ Common Stock (6,075 underlying)
Footnotes (3)
- [F1]Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
- [F3]On February 13, 2013, the Restricted Stock Units were granted with one third vesting on the first anniversary of the date of grant, one third vesting on the second anniversary of the date of grant and the remaining vesting on the third anniversary of the date of grant. As of the date of this filing, 6,075 of the Restricted Stock Units have vested.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 11:29 AM ET
- Size
- 8.9 KB